Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers.
The transcription factor SOX9 plays a crucial role in normal prostate development and has been suggested to drive prostate carcinogenesis in concert with PTEN inactivation. To evaluate the clinical impact of SOX9 and its relationship with key genomic alterations in prostate cancer, SOX9 expression w...
Main Authors: | Christoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, Claudia Hube-Magg, Martina Kluth, Nathaniel Melling, Patrick Lebok, Sarah Minner, Christina Koop, Markus Graefen, Hans Heinzer, Corinna Wittmer, Guido Sauter, Waldemar Wilczak, Ronald Simon, Thorsten Schlomm, Stefan Steurer, Till Krech |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4452277?pdf=render |
Similar Items
-
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer
by: Asmus Heumann, et al.
Published: (2018-01-01) -
VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy
by: Maria Christina Tsourlakis, et al.
Published: (2015-04-01) -
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer.
by: Nathaniel Melling, et al.
Published: (2015-01-01) -
Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer
by: Christoph Burdelski, et al.
Published: (2014-04-01) -
PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
by: Marie-Christine Heinrich, et al.
Published: (2018-05-01)